BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20447884)

  • 1. Obesity and diabetes: the links and common approaches.
    Haslam D
    Prim Care Diabetes; 2010 Jul; 4(2):105-12. PubMed ID: 20447884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy considerations in diabetes and obesity: setting patients up for success.
    Cornell S; D'Souza J
    Postgrad Med; 2014 Mar; 126(2):100-9. PubMed ID: 24685973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of diabetes in patients with severe obesity.
    Scheen AJ
    Biomed Pharmacother; 2000 Mar; 54(2):74-9. PubMed ID: 10759290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The success of bariatric surgery as treatment of type 2 diabetes should be a call to revitalize anti-obesity drug discovery and development.
    Opgenorth TJ
    Curr Opin Investig Drugs; 2008 Apr; 9(4):355-6. PubMed ID: 18393101
    [No Abstract]   [Full Text] [Related]  

  • 5. Lifestyle modifications and surgical options in the treatment of patients with obesity and type 2 diabetes mellitus.
    Ritter S; Vetter ML; Sarwer DB
    Postgrad Med; 2012 Jul; 124(4):168-80. PubMed ID: 22913905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay.
    Niswender K
    Diabetes Obes Metab; 2010 Apr; 12(4):267-87. PubMed ID: 20380648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of obesity in NIDDM (non-insulin-dependent diabetes mellitus).
    Cheah JS
    Singapore Med J; 1998 Aug; 39(8):380-4. PubMed ID: 9844503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
    Sheffield CA; Kane MP; Busch RS
    Pharmacotherapy; 2007 Oct; 27(10):1449-55. PubMed ID: 17896900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabesity: therapeutic options.
    Colagiuri S
    Diabetes Obes Metab; 2010 Jun; 12(6):463-73. PubMed ID: 20518802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical therapy for diabesity.
    Arroyo K; Kini SU; Harvey JE; Herron DM
    Mt Sinai J Med; 2010; 77(5):418-30. PubMed ID: 20960546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight loss.
    Rowe R; Cowx M; Poole C; McEwan P; Morgan C; Walker M
    Curr Med Res Opin; 2005 Nov; 21(11):1885-90. PubMed ID: 16307710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing patients with type 2 diabetes and obesity.
    Wilding J
    Practitioner; 2015 Jan; 259(1778):25-8, 3. PubMed ID: 25726618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic agents in the context of metabolic/bariatric surgery: expanding the scope and impact of diabetes drug discovery.
    Janero DR
    Expert Opin Drug Discov; 2014 Mar; 9(3):221-8. PubMed ID: 24397872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of obesity on diabetes mellitus and the role of bariatric surgery.
    Gill RS; Sharma AM; Gill SS; Birch DW; Karmali S
    Maturitas; 2011 Jun; 69(2):137-40. PubMed ID: 21493021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and type 2 diabetes: can we stop the weight gain with diabetes?
    Joffe D; Yanagisawa RT
    Med Clin North Am; 2007 Nov; 91(6):1107-23, ix. PubMed ID: 17964912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.
    Scheen AJ; Ernest P
    Diabetes Metab; 2002 Dec; 28(6 Pt 1):437-45. PubMed ID: 12522323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
    Caballero AE
    J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing childhood obesity: when lifestyle change is not enough.
    Hearnshaw C; Matyka K
    Diabetes Obes Metab; 2010 Nov; 12(11):947-57. PubMed ID: 20880341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.